Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Abstract
A single ibogaine treatment reduced opioid withdrawal symptoms and achieved opioid cessation or sustained reduced use in dependent individuals as measured over 12 months. Ibogaine's legal availability in New Zealand may offer improved outcomes where legislation supports treatment providers to work closely with other health professionals.
Topics
Opioid Use Disorder Treatment Prenatal Substance Exposure Effects Substance Abuse Treatment and OutcomesCategories
Health Sciences Medicine Public Health, Environmental and Occupational HealthTags
Addiction Depression (economics) Economics Internal medicine Macroeconomics Medicine Observational study Opioid Psychiatry Psychology ReceptorSummaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.
Referencing articles
Altered Healing
What Is Ibogaine and How Does It Work? From Plant to Powerful Therapy
Ibogaine therapy shows promise for addiction, depression, and PTSD — but safety concerns and legal…